Erkal Erzincan

Erkal Erzincan

Auto-generated profile, based on publicly available information

Erkal Erzincan

Department of Administrative and Social Sciences, İstanbul Gelişim University Faculty of Economics, İstanbul, Türkiye

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2021 in Psychiatry Investigation
Verified
Journal Article
Open access
PDF file
ŞKŞenay Kılınçel
Şenay Kılınçel
FAFeray Tarımtay Altun
Feray Tarımtay Altun
ÖNÖzgecan Nuryüz
Özgecan Nuryüz
ETEzgi Tan
Ezgi Tan
EEErkal Erzincan
Erkal Erzincan
MAMuhammed Ayaz
Muhammed Ayaz
Objective The COVID-19 outbreak has negatively affected children in many ways. This study aimed to compare the psychological responses of children exposed to different levels of stress during the COVID-19 outbreak.Methods The anxiety levels, negative thoughts, and quality of life of COVID-19-positive children with COVID-19-positive parents (Child+ group, n=17), COVID-19-negative children who are separated from COVID-19-positive parents (Parent+ group, n=59), and a control group (n=64) were compared. The participants completed the Screen for Child Anxiety and Related Disorders (SCARED), Children’s Negative Cognitive Errors Questionnaire (CNCEQ), and Pediatric Quality of Life Inventory (PedsQL).Results The statistical analysis revealed that the Parent+ group recorded higher SCARED and CNCEQ scores and lower PedsQL scores in comparison with the control group. No statistically significant difference was found between the scores of the Child+ and control groups. Furthermore, high CNCEQ scores and low PedsQL scores in the Parent+ group predicted an increase in their SCARED scores.Conclusion Our study indicates that separating children from their parents during the COVID-19 outbreak negatively influences their mental health and increases their anxiety levels.

1 January 2017 in Medeniyet Medical Journal
Verified
Journal Article
Open access
NGNermin Gündüz
Nermin Gündüz
ÖTÖzge Timur
Özge Timur
EEErkal Erzincan
Erkal Erzincan
CTCelaleddin Turgut
Celaleddin Turgut
HTHatice Turan
Hatice Turan
ZAZeynep Yıldız Akbey
Zeynep Yıldız Akbey

28 April 2025 in ALPHA PSYCHIATRY
Verified
Journal Article
Open access
PDF file
NGNermin Gündüz
Nermin Gündüz
AYAhmet Yosmaoğlu
Ahmet Yosmaoğlu
EEErkal Erzincan
Erkal Erzincan
GŞGülçin Şenyuva
Gülçin Şenyuva
Objective: Septum pellucidum is a thin midline brain structure located in the anterior brain, running in a median-sagittal or midsagittal direction. This study aims at testing whether cavum septum pellucidum (CSP) and cavum vergae (CV) could predict clozapine pre- scribing in patients with schizophrenia. This study also assesses the relationship between CSP/CV and some clinical findings in patients with schizophrenia. Methods: 190 patients diagnosed with schizophrenia who underwent neuroanatomical evaluation with magnetic resonance imaging during inpatient treatment were included in the study. A personal data form, Positive and Negative Syndrome Scale (PANSS) were given to each patient at admission and discharge. The presence or absence of CSP/CV was recorded as “yes” or “no”. Results: The presence of CSP/CV was found to be associated with the number of hospital admissions, the number of electroconvulsive therapy sessions received, PANSS total score at admission, PANSS total score at discharge and clozapine use. In the logistic regression model created, the presence of CSP and total PANSS score were found to predict clozapine prescribing (respectively p = 0.001, p = 0.016). The Nagelkerke’s R2 value was found to be 0.167. Conclusions: This study holds the distinction of being the first in the field to investigate the relationship between clozapine prescribing and the presence of CSP/CV in schizophrenia patients. There is a need for longitudinal-cohort studies that can better express effect to identify the conditions associated with CSP/CV.

23 April 2022 in Indian Journal of Otolaryngology and Head & Neck Surgery
Verified
Journal Article
Closed access
PDF file
YDYaşar Kemal Duymaz
Yaşar Kemal Duymaz
MSMehmet Surmeli
Mehmet Surmeli
EEErkal Erzincan
Erkal Erzincan
IDIldem Deveci
Ildem Deveci
HÇHasan Çanakcı
Hasan Çanakcı
COCagatay Oysu
Cagatay Oysu

10 May 2023 in Kocatepe Tıp Dergisi
Verified
Journal Article
Open access
PDF file
OGOnur Gökçen
Onur Gökçen
MAMerve Akkuş
Merve Akkuş
SESelman Erturhan
Selman Erturhan
EEErkal Erzi̇ncan
Erkal Erzi̇ncan
ABAlperen Bardakçi
Alperen Bardakçi
OBJECTIVE: In addition to respiratory symptoms, there have been reports of increased psychiatric symptoms in COVID-19 patients. In this study, it is aimed to reveal the psychiatric symptoms seen in COVID-19 patients. We also investigated the relationship between these psychiatric symptoms and peripheral inflammatory markers. MATERIAL AND METHODS: The patients were evaluated with "Interview Forms" specially created by the researchers for the study. DSM-V Acute Stress Disorder Scale (ASDS); Perceived Stress Scale-10 (PSS-10); State-Trait Anxiety Inventory (STAI-T/S); and finally Hospital Anxiety and Depression Scale (HADS) were used to determine patients' acute and perceived stress levels, depression and anxiety symptoms, state and generalized anxiety levels, and how these psychiatric symptoms were affected by different social conditions. D-dimer, fibrinogen, lymphocytes, CRP (C-reactive protein) and ferritin levels were taken into account as inflammatory markers. RESULTS: Our study included 108 inpatients and 31 outpatients with COVID-19. The ASDS, STAI State Scale, and HADS depression scale scores of inpatients patients were found to be higher compared to outpatient patients. Increased fibrinogen levels in blood tests were found to predict higher acute stress disorder scores. HAD-Depression subscale and fibrinogen levels were also found to be positively correlated with each other. CONCLUSIONS: Stress, depression and anxiety symptoms accompany COVID-19. In addition, high fibrinogen levels may be associated with psychiatric symptoms. Psychiatric symptoms are indirectly affected by physical illnesses. We can say that a pandemic that causes fear and anxiety all over the world may suppress the immune system in individuals and the suppressed immune system may indirectly make the infection more complicated.

10 July 2025 in Neuropsychiatric Investigation
Verified
Journal Article
Open access
PDF file
Merve Setenay GürbüzMerve Setenay Gürbüz
Merve Setenay Gürbüz
EEErkal Erzincan
Erkal Erzincan
FIFiliz İzCi
Filiz İzCi
EBengin emrem beştepe
engin emrem beştepe
Objective: One of the most important predictors of the severity of major depressive disorder is the presence of a comorbid anxiety disorder. Independent of treatment, depressed patients with a lifetime anxiety disorder are found to have a slower response to treatment and lower symptomatic recovery rates compared to depressed patients without a lifetime anxiety disorder. In this study, the aim was to compare the Lifetime Panic-Agoraphobic Spectrum and sociodemographic characteristics of patients with major depressive disorder and healthy controls and to investigate its relationship with depressive disorder severity and anxiety levels. Methods: A total of 135 participants were included in the study, 80 of whom were major depressive disorder patients. Beck Anxiety Scale, Beck Depression Scale, Lifetime Panic Agoraphobic Spectrum Scale, and a sociodemographic and clinical data form were applied to all participants. Results: All Lifetime Panic Agoraphobic Spectrum subscale scores, Lifetime Panic Agoraphobic Spectrum total score, Beck Depression Inventory, and Beck Anxiety Inventory scores are found to be significantly higher in the major depressive group compared to healthy controls. Also, Lifetime Panic Agoraphobic Spectrum scores and Beck Depression Inventory scores are found to be significantly higher in patients with melancholic depression compared to patients with atypical depression. Conclusion: The findings demonstrate that panic-agoraphobic spectrum characteristics are significantly associated with depression severity, especially in melancholic depression. Even in the absence of a comorbid anxiety disorder, the assessment of Panic-Agoraphobic Spectrum features and identification of the depression subtype can provide valuable insights for personalized treatment approaches and may lead to improved clinical outcomes.Cite this article as: Gürbüz MS, Erzincan E, İzci F, Beştepe EE. Evaluation of panic agoraphobic spectrum and sociodemographic characteristics in terms of depression types. Neuropsychiatr Invest. 2025, 63, 0051, doi:10.5152/ NeuropsychiatricInvest.2025.24051.